Heinrike Wilkens

Mar 18, 2024 | respiratory-research.biomedcentral.com | Frank Langer |Philipp M. Lepper |Robert Bals |Heinrike Wilkens |Bettina Weingard |Parviz Aliyev

Underlying disease was classified as restrictive (n = 18 / 56%) or obstructive (n = 12 / 38%) lung disease (Table 1: Demographic data and postoperative outcome). Two patients with prior sLTx bronchiolitis obliterans syndrome (BOS 6%) underwent sLTx of the native contralateral lung. Sex was distributed equally (male n = 16, female n = 16) among recipients—recipient age ranged from 38 to 67 years (mean 58 ± 7 years). A high LAS (> 50) was present in 6 patients, median LAS was 38 (range 31–92).

Mar 18, 2024 | respiratory-research.biomedcentral.com | Frank Langer |Philipp M. Lepper |Robert Bals |Heinrike Wilkens |Bettina Weingard |Parviz Aliyev

Underlying disease was classified as restrictive (n = 18 / 56%) or obstructive (n = 12 / 38%) lung disease (Table 1: Demographic data and postoperative outcome). Two patients with prior sLTx bronchiolitis obliterans syndrome (BOS 6%) underwent sLTx of the native contralateral lung. Sex was distributed equally (male n = 16, female n = 16) among recipients—recipient age ranged from 38 to 67 years (mean 58 ± 7 years). A high LAS (> 50) was present in 6 patients, median LAS was 38 (range 31–92).

Mar 1, 2023 | resmedjournal.com | Matthias Held |Elena Pfeuffer-Jovic |Heinrike Wilkens |Homburg Saar

The influence of the new pulmonary hypertension (PH) definition on the incidence of chronic thromboembolic PH (CTEPH) is unclear. The incidence of chronic thromboembolic pulmonary disease without PH (CTEPD) is unknown. To determine the frequency of CTEPH and CTEPD using the new mPAP cut-off >20 mmHg for PH in patients who have suffered an incidence of pulmonary embolism (PE) and were recruited into an aftercare program.